Bladder (for wee wee) Flashcards
Position of Bladder in Relation to Other Structures
- Superior and Posterior to Pelvic Bones
- Lies posterior to pubic symphysis
- Anterior to the rectum
- Inferior to the small intestine
Bladder Position as it Fills
- Neck of bladder remains fixed to prostate (only in males) and pelvic floor muscle
- It then rises into the pelvic cavity
What lines the bladder?
Transitional Epithelium (smooth when full) (folded when empty)
Epidemiology of Bladder Cancer
- Peak Incidence at 65
- More common in Caucasians
- 3x more common in males than females
Aetiology of Bladder Cancer
- Occupational exposure (naphthylamine = carcinogen in the dye industry)
- Smoking
- Chronic Bladder Infection
- Exposure to Cyclophosphamide (immunosuppressant -> for inflammation)
Signs and Symptoms of Bladder Cancer
- Haematuria (blood in urine, painless)
- Urinary irritation (frequency, urgency, pain, retention, dysuria)
- Obstruction (pain, infection, kidney damage)
Pattern of Lymphatic Spread for Bladder Cancer
Hypogastric -> Obturator -> Internal / External / Common Iliac -> Para-Aortic and Inguinal Nodes
Common Mets for Bladder Cancer
- LN’s
- Lung
- Liver
Primary and Secondary Lymphatic Drainage for Bladder Cancer
Primary Drainage: External/Internal Iliac Nodes, Obturator Nodes, Pre Sacral Nodes
Secondary Drainage: Common Iliac, Para-Aortic, Inguinal Nodes
Pathology of Bladder Cancer
- 90% are derived from TCC
- Others: Squamous Carcinoma, Adenosarcoma, Leiomyosarcoma (smooth muscle), Rhabdomyosarcoma (striated muscle)
Staging of Bladder Cancer
- TNM Staging
- TA = non-invasive and superficial
- T1 = tumour invades lumina propria and mucosa
- T2 = invades muscularis propria
- T3 = Invades peri vesical, involves deep muscle of bladder
- T4 = tumour invades neighbouring organs
Clinical Management for Superficial Bladder Cancer
- Repeated Cystoscopy (involves and remove tumour when possible)
- Cystodiathermy, cryosurgery and laser treatment
- RT is rarely used
- Tends to recur rather than invade -> follow up cystoscopy scheduled -> can be lifelong (if multiple occur chemo is used)
- Adeno/Squamo is not radio sensitive -> treated with cystectomy
Clinical Management for Muscle-Invasive Disease
- Surgery and RT is standard
- Cisplatin prior to RT is shown to improve treatment outcome by 5%
- Diagnosis is generally provided by cystoscopy
Patient Positioning and Set-up Considerations
- Empty Bladder and empty Rectum
- Supine, straight and level
- Arms on Chest
- Headrest
- Knees bolster (indexed)
- Foot stocks (indexed)
CT Simulation for Bladder Cancer
- CT Simulation Parameters: Lower border L5 -> inferior border ischial tuberosities
- Slice Thickness: 3-5 mm
- Ant Tattoo = ML / 2 Lateral Tattoos
- Confirm bladder is empty
Treatment Field Arrangement
- Options - posterior oblique fields to reduce dose to rectum)
- Concerns -> bowel and rectal changes / bladder movement
- IMRT/VMAT -> dose escalation to tumour, IGRT to locate and minimise PTV
Acute Side Effects for Bladder Cancer
- Frequency/ urgency from urination from radiation cystitis (fluid intake strongly encouraged)
- Patient may pass fragments in urine or a little fresh blood (haematuria)
- Diarrhoea, nausea, vomiting (medication & monitor)
- Local skin reaction: mild to moderate; fatigue
Late Side Effects for Bladder Cancer
- Fibrosis and shrinkage of the bladder (reduced bladder capacity)
- Haematuria - bladder telangiectasia,
- Late bowel damage,
- Vaginal dryness and Stenosis in women
- Impotence in men
Criteria for RT for Patient With Bladder Cancer
- Younger than 80
- Adequate medical condition
- Normal renal function
- No inflammatory bowel disease
- Good bladder function
- TCC
- Single tumour <7cm diameter
- No mets
Dose Fractionation
Radical: 64 Gy in 32# (daily) (across 6.5 weeks)
Palliative: 21Gy in 3# (alternate days in 1 week)
Palliative: 36Gy in 6# (given weekly for 6 weeks)
Treatment QA for Bladder Cancer
- KV imaging, kV cone beam imaging, MV imaging of gold seeds
- If IMRT/VMAT not available -> EPI (match bones with AP and LAT DRR’s daily for first 3-5 days) (once weekly following to correct for systematic errors)